Lumigen Inc. (A Beckman Coulter Company) presented a poster demonstrating the use of Andrew with their SPARCL Pharmacokinetic Immunoassay kits at the AAPS NBC event in San Diego. The poster summarizes Andrew’s accuracy and error free execution of the SPARCL kits leading to improved efficiency, reduced PK assay development and cost, all while increasing profitability. The specific poster relates to measuring IgG drug concentration in a pre-clinical setting.
Click on the below link to access the poster in full.
